Vertex Pharmaceuticals
VRTX
$437.49
Share price
2.08%
Change (1 day)
25.48%
Change (1 year)
Categories
Earnings for Vertex Pharmaceuticals (VRTX)
Earnings in 2023 (TTM): $4.42 B
According to Vertex Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $4.42 B. an increase over its 2022 earnings that were of $4.28 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Vertex Pharmaceuticals from 2003 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | $4.42 B | 3.19% |
| 2022 | $4.28 B | 53.56% |
| 2021 | $2.79 B | -12.06% |
| 2020 | $3.17 B | 118.45% |
| 2019 | $1.45 B | 120.64% |
| 2018 | $0.65 B | 1473.64% |
| 2017 | $41.86 M | 197.6% |
| 2016 | $14.06 M | -102.97% |
| 2015 | -$0.48 B | -28.46% |
| 2014 | -$0.67 B | -51.5% |
| 2013 | -$1.37 B | -30584.68% |
| 2012 | $4.47 M | -95.47% |
| 2011 | $98.89 M | |
| 2009 | -$0.6 B | |
| 2007 | -$0.42 B | 83.1% |
| 2006 | -$0.23 B | 59.02% |
| 2005 | -$0.15 B | 3.28% |
| 2004 | -$0.14 B | -38.16% |
| 2003 | -$0.23 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.36 B | 382.90% | 🇺🇸 USA |
 AbbVie ABBV | $6.25 B | 41.28% | 🇺🇸 USA |
 Gilead Sciences GILD | $6.85 B | 55.04% | 🇺🇸 USA |
 Merck MRK | $3.03 B | -31.40% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | -$5.85 B | -232.15% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | -$0.13 B | -102.92% | 🇺🇸 USA |